[1] QU C,CHEN T,FAN C,et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study:a cluster randomized controlled trial.[J] . PLos Med,2014,11(12):e1001774. [2] 徐建波,祁付珍,魏天翼,等.肝细胞肝癌血清AFP值与HBV感染的关系[J] .现代肿瘤医学,2014,22(12):2900-2902. [3] 孙维华,朱祥,尧晨光,等. 伴HBV感染性肝癌调控枢纽基因筛选与初步鉴定[J] . 生物信息学,2016,14(4):203-212. [4] 曾治民,钟琼,何静,等. Toll样受体4的表达及miR-TLR4干扰对HBV相关肝癌细胞生物学活性的影响[J] . 肿瘤防治研究,2016,43(2):116-122. [5] 王骏成,劳向明. HBV相关肝癌TACE术后HBV DNA及肝功能变化的研究进展[J] . 新医学,2016,47(5):290-294. [6] PAN W C,WU C D,CHEN M J,et al. Fine particle pollution,alanine transaminase,and liver cancer:a Taiwanese prospective cohort study (REVEAL-HBV)[J] . J Natl Cancer Inst,2015, 108(3):djv341. [7] 郎香花,章敏,陈心怡,等. HBV感染原发性肝癌患者外周血T细胞与NK细胞亚群及NKT细胞表达特点分析[J] . 中华医院感染学杂志,2016,26(17):3883-3885. [8] 冯子明,袁中平,董谢平,等. 转移瘤CD34及微血管表达的研究[J] . 实用临床医学,2014,15(6):33-35. [9] RINGELHAN M,O'CONNOR T,PROTZER U,et al. The direct and indirect roles of HBV in liver cancer:prospective markers for HCC screening and potential therapeutic targets[J] . J Pathl,2015,235(2):355-67. [10] 付承林,赵秀敏,陈灵斌,等. HBV感染型原发性肝癌患者肿瘤微环境中T细胞亚群及VEGF表达水平及临床意义[J] . 中华医院感染学杂志,2017,27(7):1490-1493. [11] ALBIRAIR M T. Evaluating the association between hbv vaccination coverage and the incidence of liver cancer at a global level[D] . Seattle:University of Washington,2015:1-9. [12] LIU L,QIN S,ZHENG Y,et al. Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo[J] . Cancer bio ther,2017,18(3):166-176.